Mini review article. Human herpesvirus-6 and the etiology of multiple sclerosis: a literature review

Open access

Abstract

Background: There is no consensus in the literature on the role of human herpes virus-6 (HHV-6) in multiple sclerosis (MS) onset or progression.

Objective: We evaluated a possible role for HHV-6 in MS onset and progression.

Methods: We conducted a literature search of PubMed and Google scholar with the following search terms: (“multiple sclerosis” OR “MS”) and (“Human Herpes Virus-6” OR “HHV-6”).

Results: A total 21 publications were retrieved, of which 19 case-control studies were included. A further 25 articles were retrieved for background information.

Conclusion: There was insufficient evidence to support a role of HHV-6 in MS onset and progression.

1. Enbom M, Wang F-Z, Fredrikson S, Martin C, Dahl H, Linde A. Similar humoral and cellular immunological reactivities to human herpesvirus 6 in patients with multiple sclerosis and controls. Clin Diagn Lab Immunol. 1999; 6:545-9

2. Mancuso R, Delbue S, Borghi E, Pagani E, Calvo MG, Caputo D, et al. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis. J Med Virol. 2007; 79:192-9

3. Challoner PB, Smith KT, Parker JD, Macleod DL, Coulter SN, Rose TN, et al. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA. 1995; 92:7440-4.

4. Enbom M. Human herpesvirus 6 in the pathogenesis of multiple sclerosis. APMIS. 2001; 109:401-11.

5. Stinissen P, Raus J, Zhang J. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol. 1997; 17:33-75.

6. Hunter SF, Hafler DA. Ubiquitous pathogens. Links between infection and autoimmunity in MS? Neurology. 2000; 55:164-5.

7. Brown KA. Factors modifying the migration of lymphocytes across the blood-brain barrier. Int Immunopharmacol. 2001; 1:2043-62.

8. Bruck W. Clinical implications of neuropathological findings in multiple sclerosis. J Neurol. 2005; 252:III/ 10-4.

9. Harbige LS, Sharief MK. Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis. Br J Nutr. 2007; 98:S46-53.

10. Gompels UA, Nicholas J, Lawrence G, Jones M, Thomson BJ, Martin MED, et al. The DNA sequence of human herpes virus-6 structure, coding content and genome evolution. Virology. 1995; 209:29-51.

11. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpesviridae in post-mortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neurovirol. 1996; 2:249-58.

12. Taus C, Pucci E, Cartechini E, Fie A, Guiliani G, Clementi M, et al. Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. Acta Neurol Scand. 2000; 101:224-8.

13. Opsahl ML, Kennedy PGE. Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain. 2005; 128:516-27.

14. Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samart☐n A, Sanchez-Gomez MV. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 2001; 24: 224-30.

15. Miller G. The dark side of glia. Science. 2005; 308: 778-81.

16. Farooqui AA, Horrocks LA, Farooqui T. Modulation of inflammation in brain: a matter of fat. J Neurochem. 2007; 101:577-99.

17. Clark DA. Human herpesvirus 6 and multiple sclerosis. Herpes. 1999; 6:73-7.

18. Gopfert E, Pytlik S, Debuch H. 2′,3′-Cyclic nucleotide 3′-phosphohydrolase and lipids of myelin from multiple sclerosis and normal brains. J Neurochem. 1980; 34: 732-9.

19. Martin C, Enbom M, Soderstrom M, Fredrikson S, Dahl H, Lycke J, et al. Absence of seven human herpesviruses, Including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurol Scand. 1997; 95:280-3.

20. Franciotta D, Bestetti A, Sala S, Perucca P, Jarius S, Price RW, et al. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum. Acta Neurol Belg. 2009; 109:277-82.

21. Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Dominguez-Mozo MI, Bartolome M, Benito- Martin MS, et al. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler. 2008; 14:595-601.

22. Mancuso R, Hernis A, Cavarretta R, Caputo D, Calabrese E, Nemni R, et al. Detection of viral DNA sequences in the cerebrospinal fluid of patients with Multiple Sclerosis. J Med Virol. 2009; 82:1051-7.

23. Sotelo J, Ordonez G, Pineda B, Flores J. The participation of varicella zoster virus in relapses of multiple sclerosis. Clin Neurol Neurosurg. 2014; 119: 44-8.

24. van Nierop GP, Hintzen RQ, Verjans GMGM. Prevalence of human Herpesviridae in cerebrospinal fluid of patients with multiple sclerosis and noninfectious neurological disease in the Netherlands. J. Neurovirol. 2014; DOI 10.1007/s13365-014-0248-4.

25. Mechelli R, Vittori D, Coarelli G, Aimati L, De Luca O, Romano S, et al. Screening for neurotropic viruses in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. MSJ. 2014; 20:638.

26. Ahram M, El-Omar A, Baho Y, Lubad MA. Association between human herpesvirus 6 and occurrence of multiple sclerosis among Jordanian patients. Acta Neurol Scand. 2009; 120:430-5.

27. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: Results of an international survey. Neurology. 1996; 46:907-11.

28. Reipert B. Multiple sclerosis: a short review of the disease and its differences between men and women. J Men’s Health Gen. 2004; 1:334-40.

29. Secchiero P, Zella D, Crowley RW, Gallo RC, Lusso P. Quantitative PCR for human herpesviruses 6 and 7. J Clin Microbiol. 1995; 33:2124-30.

30. Chapenko S, Millers A, Nora Z, Logina I, Kukaine R, Murovska M. Correlation between HHV-6 reactivation and multiple sclerosis disease activity. J Med Virol. 2003; 69:111-7.

31. Alvarez-Lafuente R, Martin-Estefania C, de Las Heras V, Castrillo C, Picazo JJ, Varela de Seijas E, et al. Active human herpesvirus 6 infection in patients with multiple sclerosis. Arch Neurol. 2002; 59:929-33.

32. Behzad-Behbahani A, Hadi Mikaeili M, Entezam M, Mojiri A, Pour GY, Arasteh MM, et al. Human herpesvirus-6 viral load and antibody titer in serum samples of patients with multiple sclerosis. J Microbiol Immunol Infect. 2011; 44:247-51.

33. Ohyashiki JH, Takaku T, Ojima T, Abe K, Yamamoto K, Zhang Y, et al. Transcriptional profiling of human herpesvirus type B (HHV-6B) in an adult T cell leukemia cell line as an in vitro model for persistent infection. Biochem Biophys Res Commun. 2005; 329:11-7.

34. Adams CWM. Pathology of multiple sclerosis: progression of the lesion. Br Med Bull. 1977; 33:15-20.

35. Hay KA, Tenser RB. Leukotropic herpesviruses in multiple sclerosis. Mult Scler. 2000; 6:66-8.

36. Sotelo J, Ordonez G, Pineda B. Varicella-zoster virus at relapses of multiple sclerosis. J Neurol. 2007; 254: 493-500.

37. Hon GM, Erasmus RT, Matsha T. Low prevalence of human herpesvirus-6 and varicella zoster virus in blood of multiple sclerosis patients, irrespective of inflammatory status or disease progression. J Clin Neurosci. 2014; doi:

38. Fredj NB, Rotola A, Nefzi F, Chebel S, Rizzo R, Caselli E, et al. Identification of human herpesviruses 1 to 8 in Tunisian multiple sclerosis patients and healthy blood donors. J Neurovirol. 2006; 18:12-9.

39. Mameli G, Astone V, Arru G, Marconi S, Lovato L, Serra C, et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6. J Gen Virol. 2007; 88:264-74.

40. Alvarez-Lafuente R, Martin-Estefania C, de las Heras V, Castrillo C, Cour I, Picazo JJ, et al. Prevalence of herpesvirus DNA in MS patients and healthy blood donors. Acta Neurol Scand. 2002; 105:95-9.

41. Ablashi DV, Eastman HB, Owen CB, Roman MM, Friedman J, Zabriskie JB, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000; 16: 179-91.

42. Ben-Fredj N, Ben-Selma W, Rotola A, Nefzi F, Benedetti S, Frih-Ayed M, et al. Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients. J Neurovirol. 2013; 19:42-7.

43. Alvarez-Lafuente R, de las Heras V, Bartolome M, Picazo JJ, Arroyo R. Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Arch Neurol. 2004; 61:1523-7.

44. Schippling S, Heesen C, Zander A, Martin R. Stem cell transplantation in multiple sclerosis. J Neurol. 2008; 255:43-7.

45. Compston A, Coles A. Multiple sclerosis. Lancet. 2002; 359:1221-31.

46. Chatzimanolis N, Kraus J, Bauer R, Engelhardt B, Bregenzer T, Kuehne BS, et al. CD45RA + ICAM-3 + lymphocytes in interferon-β1b-treated and -untreated patients with relapsing-remitting multiple sclerosis. Acta Neurol Scand. 2004; 110:377-85.

47. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology. 1983; 33:1444-52.

48. Gustafsson R, Reitsma R, Stralfors A, Lindholm A, Press R, Fogdell-Hahn A. Incidence of human herpesvirus 6 in clinical samples from Swedish patients with demyelinating diseases. J Microbiol Immunol Infect. 2013; doi:

Journal Information


IMPACT FACTOR 2017: 0.209
5-year IMPACT FACTOR: 0.243

CiteScore 2017: 0.24

SCImago Journal Rank (SJR) 2017: 0.162
Source Normalized Impact per Paper (SNIP) 2017: 0.173

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 116 116 18
PDF Downloads 33 33 4